ARTICLE | Distillery Therapeutics
TMED9 inhibition for mucin 1 kidney disease
August 15, 2019 8:08 PM UTC
Blocking the vesicular cargo receptor TMED9 could treat mucin 1 kidney disease, a proteinopathy caused by a frameshift mutation in MUC1, and other misfolded protein diseases. The Harvard researchers i...
BCIQ Company Profiles